ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) IN THE ELDERLY PATIENTS (AGE > 65 YEARS) WITH ACUTE MYELOID LEUKEMIA (AML) IS SAFE AND EFFECTIVE

被引：0
|
作者：
Jagadeesh, D. [1 ,2 ]
Cerny, J. [1 ,2 ]
Ramanathan, M. [1 ,2 ]
Raffel, G. D. [1 ,2 ]
Petrillo-Deluca, L. [2 ]
Tarrasky, N. [2 ]
Krumpe, L. M. [2 ]
Bednarik, J. [2 ]
Barton, B. A. [1 ]
Walsh, W., V [1 ,2 ]
Nath, R. [1 ,2 ]
机构：
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
[2] UMass Mem Med Ctr, Worcerster, MA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2012年 / 18卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2011.12.512
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
237
引用
收藏
页码：S292 / S292
页数：1
相关论文
共 50 条
  • [1] Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT)
    Siddhartha Ganguly
    Manik Amin
    Clint Divine
    Omar S. Aljitawi
    Sunil Abhyankar
    Joseph P. McGuirk
    [J]. Annals of Hematology, 2013, 92 : 549 - 550
  • [2] Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT)
    Ganguly, Siddhartha
    Amin, Manik
    Divine, Clint
    Aljitawi, Omar S.
    Abhyankar, Sunil
    McGuirk, Joseph P.
    [J]. ANNALS OF HEMATOLOGY, 2013, 92 (04) : 549 - 550
  • [3] Allogeneic Stem Cell Transplantation (allo-SCT) for Secondary Acute Myeloid Leukemia (AML) Following Breast Carcinoma.
    Ayari, Sameh
    Mohty, Mohamad
    Bilger, Karin
    Guillerm, Gaelle
    Guyotat, Denis
    Michallet, Mauricette
    Ifrah, Norbert
    Chevallier, Patrice
    [J]. BLOOD, 2009, 114 (22) : 1281 - 1282
  • [4] Cure by chemotherapy without allogeneic stem cell transplantation (ALLO-SCT) in pediatric relapsed acute myeloid leukemia (AML)?
    Kaspers, G. J. L.
    Goemans, B. F.
    Korbijn, C.
    Tamminga, R. Y.
    Hahlen, K.
    [J]. ANNALS OF HEMATOLOGY, 2008, 87 : S3 - S3
  • [5] Allogeneic stem cell transplantation (allo-SCT) in patients with advanced-phase acute leukemia
    Michalakeas, I
    Baltathakis, I
    Karakasis, D
    Delistrati, V
    Poulopoulou, Z
    Bika, E
    Skandalis, A
    Harhalakis, N
    Nikiforakis, E
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S81 - S81
  • [6] Reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) for patients with acute myeloid leukemia (AML): A donor versus no donor comparison
    Mohty, M
    de Lavallade, H
    Ladaique, P
    Faucher, C
    Vey, N
    Coso, D
    Stoppa, AM
    Gastaut, JA
    Blaise, D
    [J]. BLOOD, 2005, 106 (11) : 439B - 439B
  • [7] EFFECTS OF CHANGES IN CONDITIONING REGIMEN AND SUPPORTIVE CARE ON OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT)
    Abello, V
    Rosales, C.
    Pedraza, E.
    Linares, A.
    Esguerra, H.
    Rosales, M.
    Figueroa, J.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S232 - S232
  • [8] Allogeneic stem cell transplantation (allo-SCT) in adult acute lymphoblastic leukemia (ALL)
    Wu, S. J.
    Yao, M.
    Tang, J. L.
    Chen, Y. C.
    Cheng, A. L.
    Tien, H. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Postremission treatment with chemotherapy or allogeneic stem cell transplantation (allo-SCT) in adults with acute myeloid leukemia (AML) - JALSG AML-97 trial.
    Sakamaki, H
    Miyawaki, S
    Kishimoto, Y
    Miyazaki, Y
    Asou, N
    Ogawa, Y
    Honda, S
    Ohno, R
    [J]. BLOOD, 2004, 104 (11) : 632A - 632A
  • [10] RUNX1 Mutation is Associated with Poor Outcome in Patients with Acute Myeloid Leukemia (AML) who Received Allogeneic Stem Cell Transplantation (allo-SCT)
    Chan, Onyee
    Jennings, Michelle
    Asghari, Hannah
    Song, Jinming
    Hussaini, Mohammad
    Sallman, David
    Padron, Eric
    Komrokji, Rami
    List, Alan
    Lancet, Jeffrey
    Mishra, Asmita
    Sweet, Kendra
    Talati, Chetasi
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S233 - S233
12345